By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Statin > Lovastatin

Lovastatin

GMJ
Last updated: 01/06/2026 20:19
By
GMJ News Desk
Share
5 Min Read
SHARE
3 min read|603 words

Lovastatin Drug Profile

What is Lovastatin?

Lovastatin is a cholesterol-lowering medication belonging to a class of drugs called statins (HMG-CoA reductase inhibitors). It is primarily prescribed to reduce high cholesterol levels and lower the risk of cardiovascular disease in patients with elevated blood lipid levels. Lovastatin was one of the first statins approved for clinical use and remains an important treatment option for managing hypercholesterolemia.

Uses

Lovastatin is approved for several cardiovascular-related conditions:

  • Primary hypercholesterolemia: Reducing elevated LDL (“bad”) cholesterol and total cholesterol levels in patients with high cholesterol
  • Mixed dyslipidemia: Managing patients with multiple lipid abnormalities, including high cholesterol and triglycerides
  • Cardiovascular disease prevention: Reducing the risk of heart attacks, strokes, and other cardiovascular events in patients with risk factors
  • Familial hypercholesterolemia: Treating inherited forms of high cholesterol, often in combination with other therapies
  • Secondary prevention: Reducing cardiovascular risk in patients who have already experienced heart disease or stroke

How it works

Lovastatin works by blocking an enzyme called HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver. By inhibiting this enzyme, lovastatin reduces the liver’s ability to manufacture cholesterol, forcing the body to remove more cholesterol from the bloodstream. This mechanism effectively lowers total cholesterol, LDL cholesterol, and triglyceride levels while modestly increasing HDL (“good”) cholesterol.

Side effects

Common side effects:

Submit Your Paper
GMJ_Submit_Banner
  • Headache
  • Muscle aches or weakness
  • Abdominal pain
  • Nausea
  • Diarrhea
  • Constipation
  • Dizziness
  • Skin rash

Serious side effects requiring immediate medical attention:

  • Severe muscle pain, weakness, or tenderness (possible rhabdomyolysis)
  • Dark-colored urine
  • Yellowing of skin or eyes (jaundice)
  • Severe abdominal pain
  • Unexplained fatigue or weakness

Warnings and precautions

  • Liver function: Regular liver enzyme monitoring is required, as statins can cause liver damage in rare cases. Patients with active liver disease should not use lovastatin.
  • Muscle toxicity: Risk of muscle damage increases with higher doses and certain drug combinations. Patients should report unexplained muscle pain immediately.
  • Pregnancy and breastfeeding: Lovastatin is contraindicated during pregnancy and breastfeeding due to potential harm to the developing fetus or infant.
  • Age considerations: Elderly patients may be more susceptible to muscle-related side effects and may require lower doses or more frequent monitoring.
  • Kidney impairment: Patients with severe kidney disease may require dose adjustments or alternative treatments.

Interactions

Lovastatin has several important drug interactions that can increase the risk of side effects:

  • Gemfibrozil: Significantly increases muscle toxicity risk and is generally contraindicated with lovastatin
  • Warfarin: May enhance anticoagulant effects, requiring more frequent INR monitoring
  • Cyclosporine: Increases lovastatin levels and muscle toxicity risk
  • Macrolide antibiotics (erythromycin, clarithromycin): Can increase statin levels and side effect risk
  • Antifungal medications (itraconazole, ketoconazole): May significantly increase lovastatin concentrations
  • Grapefruit juice: Can increase drug levels when consumed in large quantities
  • Niacin (high doses): May increase muscle-related side effects when combined with statins
  • Digoxin: Statin therapy may slightly increase digoxin levels

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosing for lovastatin ranges from 20 to 80 mg taken once daily with the evening meal, as cholesterol synthesis occurs primarily at night. Most patients begin with 20 mg daily, with dose adjustments made based on cholesterol levels and tolerance. The maximum recommended dose is 80 mg daily, though this higher dose is reserved for patients who have not achieved target cholesterol levels with lower doses and have been on 40 mg for at least one month. Dosage should always be individualized and determined by a healthcare provider based on the patient’s specific condition, response to treatment, and risk factors.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Lovastatin." GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/drug/lovastatin-5/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Endometriosis Affects 10% of Women Yet Faces Chronic Under-recognition, BBC Investigation Reveals

BBC investigation reveals endometriosis affects 10% of women yet faces chronic under-recognition,…

Medical School Diversity Gains Not Translating to Diverse Physician Workforce

Despite medical schools successfully diversifying enrollment, these gains aren't translating to physician…

Maternity Staff Used Offensive Terms for Patients, BBC Investigation Reveals

BBC Panorama investigation reveals maternity staff at Nottingham University Hospitals NHS Trust…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Simvastatin

By
GMJ News Desk
01/06/2026

Fluvastatin

By
GMJ News Desk
01/06/2026

Pravastatin

By
GMJ News Desk
01/06/2026

Rosuvastatin

By
GMJ News Desk
01/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up